Summary
57 / 100 · Bulios Score
What speaks for it
- Out of every 100 INR of revenue, 6.7 INR is left as net profit.
- Analysts expect revenue to grow by 22% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 2.5% a year over the last 3 years.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 32.4 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (INR)
Diluted EPS (INR)
- Analyst estimate
Revenue grew by 45% a year over 5 years. Over the last 3 years it fell by 2.5% a year. For the next fiscal year analysts expect revenue to grow by 22%. Earnings per share fell by 3.3% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 63 INR
- Sales and administration 27 INR
- Taxes and other 2.8 INR
- Net profit 6.7 INR
Net profit, industry median (Chemicals - Specialty) 6.1 INR
Out of every 100 INR of revenue, 6.7 INR is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.39%
- Paid out of profit
- 13%
You receive ₹2.50 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail